Music Therapy in Sickle Cell Transition Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02466555 |
Recruitment Status :
Completed
First Posted : June 9, 2015
Results First Posted : September 13, 2019
Last Update Posted : September 13, 2019
|
Sponsor:
University Hospitals Cleveland Medical Center
Collaborator:
Kulas Foundation
Information provided by (Responsible Party):
Samuel Rodgers-Melnick, University Hospitals Cleveland Medical Center
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment |
Condition |
Sickle Cell Disease |
Intervention |
Behavioral: Music Therapy |
Enrollment | 30 |
Participant Flow
Recruitment Details | |
Pre-assignment Details | Thirty-three participants with SCD were approached for recruitment. Three declined due to scheduling conflicts or disinterest. Thirty (90.9%) participants agreed to participate and completed written consent. |
Arm/Group Title | Music Therapy Group |
---|---|
![]() |
Music Therapy: During the educational music therapy intervention, member(s) of the Adult Sickle Cell Disease team will share with the patients the medical information pertinent to the appointment, ask health related questions of the patients and respond to any pertinent inquiries. The Music Therapist will then engage the patients and member(s) of the Adult Sickle Cell Disease team in a music therapy intervention designed to teach and reinforce the skills and knowledge presented. These music therapy interventions may |
Period Title: Overall Study | |
Started | 30 |
Completed | 28 |
Not Completed | 2 |
Reason Not Completed | |
Lost to Follow-up | 2 |
Baseline Characteristics
Arm/Group Title | Music Therapy Group | |
---|---|---|
![]() |
Music Therapy: During the educational music therapy intervention, member(s) of the Adult Sickle Cell Disease team will share with the patients the medical information pertinent to the appointment, ask health related questions of the patients and respond to any pertinent inquiries. The Music Therapist will then engage the patients and member(s) of the Adult Sickle Cell Disease team in a music therapy intervention designed to teach and reinforce the skills and knowledge presented. These music therapy interventions may include but are not limited to original songs/rap/instrumental playing, vocal and/or instrumental improvisation, patient-contributed lyrics, mnemonics, and stress and pain reducing strategies. The music therapy interventions will be tailored to best convey the educational message. | |
Overall Number of Baseline Participants | 28 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 28 participants | |
<=18 years | 0 | |
Between 18 and 65 years | 28 | |
>=65 years | 0 | |
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||
Number Analyzed | 28 participants | |
21.04 (1.40) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 28 participants | |
Female |
14 50.0%
|
|
Male |
14 50.0%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 28 participants | |
American Indian or Alaska Native |
0 0.0%
|
|
Asian |
0 0.0%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
|
Black or African American |
28 100.0%
|
|
White |
0 0.0%
|
|
More than one race |
0 0.0%
|
|
Unknown or Not Reported |
0 0.0%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
United States | Number Analyzed | 28 participants |
28 | ||
Type of Sickle Cell Disease
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 28 participants | |
HbSS |
19 67.9%
|
|
HbSC |
6 21.4%
|
|
HbSBeta+ Thalassemia |
2 7.1%
|
|
HbSBeta0 Thalassemia |
1 3.6%
|
|
Sickle Cell Disease Treatment
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 28 participants | |
Hydroxyurea |
7 25.0%
|
|
Chronic transfusions |
9 32.1%
|
|
None |
12 42.9%
|
Outcome Measures
Adverse Events
Limitations and Caveats
Limitations to this study include missing data from some participants, lack of a control group, convenience sampling and small sample size.
More Information
Results Point of Contact
Name/Title: | Samuel Rodgers-Melnick, MT-BC, music therapist |
Organization: | University Hospitals Connor Integrative Health Network |
Phone: | 216-844-7727 |
EMail: | Samuel.RodgersMelnick@UHhospitals.org |
Responsible Party: | Samuel Rodgers-Melnick, University Hospitals Cleveland Medical Center |
ClinicalTrials.gov Identifier: | NCT02466555 |
Other Study ID Numbers: |
03-15-30 |
First Submitted: | June 4, 2015 |
First Posted: | June 9, 2015 |
Results First Submitted: | November 1, 2018 |
Results First Posted: | September 13, 2019 |
Last Update Posted: | September 13, 2019 |